Literature DB >> 12134160

Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta.

José G Abreu1, Nan I Ketpura, Bruno Reversade, E M De Robertis.   

Abstract

Connective-tissue growth factor (CTGF) is a secreted protein implicated in multiple cellular events including angiogenesis, skeletogenesis and wound healing. It is a member of the CCN family of secreted proteins, named after CTGF, cysteine-rich 61 (CYR61), and nephroblastoma overexpressed (NOV) proteins. The molecular mechanism by which CTGF or other CCN proteins regulate cell signalling is not known. CTGF contains a cysteine-rich domain (CR) similar to those found in chordin and other secreted proteins, which in some cases have been reported to function as bone morphogenetic protein (BMP) and TGF-beta binding domains. Here we show that CTGF directly binds BMP4 and TGF-beta 1 through its CR domain. CTGF can antagonize BMP4 activity by preventing its binding to BMP receptors and has the opposite effect, enhancement of receptor binding, on TGF-beta 1. These results show that CTGF inhibits BMP and activates TGF-beta signals by direct binding in the extracellular space.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134160      PMCID: PMC2387275          DOI: 10.1038/ncb826

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  30 in total

1.  Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos.

Authors:  W C Smith; R M Harland
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

2.  Ventroptin: a BMP-4 antagonist expressed in a double-gradient pattern in the retina.

Authors:  H Sakuta; R Suzuki; H Takahashi; A Kato; T Shintani; T S Yamamoto; N Ueno; M Noda
Journal:  Science       Date:  2001-07-06       Impact factor: 47.728

3.  CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling.

Authors:  A Holmes; D J Abraham; S Sa; X Shiwen; C M Black; A Leask
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

4.  A novel chordin-like protein inhibitor for bone morphogenetic proteins expressed preferentially in mesenchymal cell lineages.

Authors:  N Nakayama; C E Han ; S Scully; R Nishinakamura; C He; L Zeni; H Yamane; D Chang; D Yu; T Yokota; D Wen
Journal:  Dev Biol       Date:  2001-04-15       Impact factor: 3.582

5.  Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.

Authors:  Isao Inoki; Takayuki Shiomi; Gakuji Hashimoto; Hiroyuki Enomoto; Hiroyuki Nakamura; Ken-ichi Makino; Eiji Ikeda; Shigeo Takata; Ken-ichi Kobayashi; Yasunori Okada
Journal:  FASEB J       Date:  2001-12-14       Impact factor: 5.191

6.  Inner cell mass-specific expression of a cell adhesion molecule (PECAM-1/CD31) in the mouse blastocyst.

Authors:  P Robson; P Stein; B Zhou; R M Schultz; H S Baldwin
Journal:  Dev Biol       Date:  2001-06-15       Impact factor: 3.582

7.  The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor.

Authors:  P R Segarini; J E Nesbitt; D Li; L G Hays; J R Yates; D F Carmichael
Journal:  J Biol Chem       Date:  2001-08-22       Impact factor: 5.157

Review 8.  Connective tissue growth factor: what's in a name?

Authors:  E E Moussad; D R Brigstock
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

9.  Proteolytic cleavage of Chordin as a switch for the dual activities of Twisted gastrulation in BMP signaling.

Authors:  J Larraín; M Oelgeschläger; N I Ketpura; B Reversade; L Zakin; E M De Robertis
Journal:  Development       Date:  2001-11       Impact factor: 6.868

10.  BMP-binding modules in chordin: a model for signalling regulation in the extracellular space.

Authors:  J Larraín; D Bachiller; B Lu; E Agius; S Piccolo; E M De Robertis
Journal:  Development       Date:  2000-02       Impact factor: 6.868

View more
  294 in total

1.  Report on the second international workshop on the CCN family of genes.

Authors:  B Perbal; D R Brigstock; L F Lau
Journal:  Mol Pathol       Date:  2003-04

2.  Soluble repulsive guidance molecule c/hemojuvelin is a broad spectrum bone morphogenetic protein (BMP) antagonist and inhibits both BMP2- and BMP6-mediated signaling and gene expression.

Authors:  Mahta Nili; Ujwal Shinde; Peter Rotwein
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

3.  Connective tissue growth factor is required for skeletal development and postnatal skeletal homeostasis in male mice.

Authors:  Ernesto Canalis; Stefano Zanotti; Wesley G Beamer; Aris N Economides; Anna Smerdel-Ramoya
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

4.  SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.

Authors:  Barbara J Schiemann; Jason R Neil; William P Schiemann
Journal:  Mol Biol Cell       Date:  2003-06-27       Impact factor: 4.138

5.  The time has come to target connective tissue growth factor in diabetic complications.

Authors:  S M Twigg; M E Cooper
Journal:  Diabetologia       Date:  2004-05-28       Impact factor: 10.122

Review 6.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

Review 7.  The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.

Authors:  John A Arnott; Alex G Lambi; Christina Mundy; Honey Hendesi; Robin A Pixley; Thomas A Owen; Fayez F Safadi; Steven N Popoff
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

8.  Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts.

Authors:  Rongrong Zhang; Babatunde O Oyajobi; Stephen E Harris; Di Chen; Christopher Tsao; Hong-Wen Deng; Ming Zhao
Journal:  Bone       Date:  2012-09-29       Impact factor: 4.398

9.  The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth.

Authors:  Kevin L Bennewith; Xin Huang; Christine M Ham; Edward E Graves; Janine T Erler; Neeraja Kambham; Jonathan Feazell; George P Yang; Albert Koong; Amato J Giaccia
Journal:  Cancer Res       Date:  2009-02-01       Impact factor: 12.701

10.  Triple combination of siRNAs targeting TGFβ1, TGFβR2, and CTGF enhances reduction of collagen I and smooth muscle actin in corneal fibroblasts.

Authors:  Sriniwas Sriram; Paulette Robinson; Liya Pi; Alfred S Lewin; Gregory Schultz
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-17       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.